Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for Diabetic Foot Ulcers
NCT02675335Phase 3Withdrawn
- Start
- Mar 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of sitagliptin in diabetic foot ulcer (DFU). Planned start Mar 2016; status: withdrawn.
02
Drugs
sitagliptin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02675335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02675335.